Hugo A. Tejeda - Concepedia

Author

Hugo A. Tejeda

Also Known As

H TEJEDA, H. A. Tejeda, Hugo A Tejeda, Hugo A. Tejeda, Hugo Tejeda, Hugo A. Tejeda, Tejeda, Hugo, Tejeda, Hugo Alejandro

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Institute of Mental Health National Institute on Drug Abuse University of Maryland, Baltimore The University of Texas at El Paso

About

Hugo A. Tejeda is an author at National Institutes of Health specializing in medicine, neuroscience, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.4K
2	Social Sciences	10	10	882
3	Health Sciences	5	5	281
4	Behavioral Sciences	4	4	380
5	Public Health	2	2	197

Hugo A. Tejeda

Publications

Citations

H-Index

Page 1

	Year	Citations
Representation of African-Americans, Hispanics, and Whites in National Cancer Institute Cancer Treatment Trials Hugo A. Tejeda, S. B. Green, Edward L. Trimble, JNCI Journal of the National Cancer Institute	1996	273
Juvenile Antioxidant Treatment Prevents Adult Deficits in a Developmental Model of Schizophrenia Jan-Harry Cabungcal, Danielle S. Counotte, Eastman M. Lewis, Neuron PsychiatryPsychotic DisorderPsychopharmacologySchizophreniaSocial Sciences	2014	194
Enhanced vulnerability to the rewarding effects of nicotine during the adolescent period of development Omar Torres, Hugo A. Tejeda, Luis A. Natividad, Pharmacology Biochemistry and Behavior Substance AbuseBehavioral SciencesSubstance UseTobacco UseAddiction	2008	168
Circuit specificity in the inhibitory architecture of the VTA regulates cocaine-induced behavior Nick J. Edwards, Hugo A. Tejeda, Marco Pignatelli, Nature Neuroscience Psychoactive DrugBehavioral NeuroscienceAddictionMedicineNeurotransmitter	2017	150
Microglial activation elicits a negative affective state through prostaglandin-mediated modulation of striatal neurons Anna M. Klawonn, Michael Fritz, Sílvia Castany, Immunity PsychoneuroimmunologyNegative Affective StateMicroglial ActivationMedicineAffective Neuroscience	2021	150
Pathway- and Cell-Specific Kappa-Opioid Receptor Modulation of Excitation-Inhibition Balance Differentially Gates D1 and D2 Accumbens Neuron Activity Hugo A. Tejeda, Jocelyn Wu, Alana R. Kornspun, Neuron MedicinePhysiologyNeurotransmitterNeuropeptide ReceptorNeuropharmacology	2017	147
Prefrontal Cortical Kappa-Opioid Receptor Modulation of Local Neurotransmission and Conditioned Place Aversion Hugo A. Tejeda, Danielle S. Counotte, Eric J. Oh, Neuropsychopharmacology Conditioned Place AversionHealth SciencesPsychiatryBehavioral NeuroscienceAddiction	2013	130
Female rats display dose-dependent differences to the rewarding and aversive effects of nicotine in an age-, hormone-, and sex-dependent manner Oscar V. Torres, Luis A. Natividad, Hugo A. Tejeda, Psychopharmacology Tobacco ControlSubstance AbuseBehavioral SciencesBehavioral NeuroscienceAddiction	2009	112
Amygdala inputs drive feedforward inhibition in the medial prefrontal cortex Jonathan E. Dilgen, Hugo A. Tejeda, Patricio O’Donnell Journal of Neurophysiology NeuropsychologyBrain FunctionInhibitory ProcessAffective NeuroscienceNeurotransmission	2013	96
Adolescent nicotine exposure produces less affective measures of withdrawal relative to adult nicotine exposure in male rats Laura E. O’Dell, Oscar V. Torres, Luis A. Natividad, Neurotoxicology and Teratology Tobacco ControlSubstance AbuseBehavioral SciencesSubstance UseWithdrawal Relative	2006	85

Page 1